NCT04928573View on ClinicalTrials.gov

Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

July 29, 2022

Study Completion Date

March 23, 2023

Conditions
Diffuse Large B Cell Lymphoma
Trial Locations (1)

13083-878

Dr Fernando Pericole, Campinas

All Listed Sponsors
lead

Libbs Farmacêutica LTDA

INDUSTRY